Theres no separate membership or platform fee
The GLP-1 receptor activation slows gastric emptying, meaning food sits in your stomach longer and maintains feelings of fullness
Initially approved by the FDA for the treatment of type 2 diabetes, its remarkable effectiveness in promoting weight loss has led to significant interest and broader application in weight management
Lower doses can sometimes reduce nausea, bloating, constipation, and other gastrointestinal side effects
Tyna brings a unique perspective to those wishing to build a more robust foundation for their health and well-being
Backlash and a fuzzy future Murmurs of a backlash against the escalated approval of GLP-1s in India went beyond social media, to the Indian judiciary in 2025 long predating the Indian governments official guidelines for the usage of these drugs, which came out in the first week of April